Dr. Thierry Teil (MD) is a seasoned professional in Pharmaceutical Industry and until recently served as VP Global Medical Affairs at NPS Pharmaceuticals (April 2014 – May 2015). In his role at NPS, he was responsible for building the Global Medical Affairs department, oversee Phase IIIB/IV, IIS and registries, provide medical input and leadership into all strategic and tactical dimensions of the company, supported the launch of Gattex/Revestive in Europe, Latin America, USA , and Canada; supported the launch of Natpara/Natpar worldwide.
Previously, he served at UCB Pharma from 2006-2014 and held executive responsibilities like VP Global Medical Affairs (2006-2009), and Managing Director Russia/CIS (2006-2014). He holds his expertise in late stage development, Medical Affairs, Marketing, Market Access, Emerging Markets, project leadership and alliance management. Prior to UCB, he served as Executive Director at The medicines Company, Angiomax ACS Project Leader and Head of Strategic Partnership and Alliance Management. He also served at Aventis and parent companies (now Sanofi) for 13 years with growing responsibilities in Global Marketing and Medical Affairs, Project Leadership and General Management. Thierry is also an entrepreneur, senior advisor at Triana Venture Partners, co-founder of International Regenerative Medicine Inc., and co-founder of Peptinov. He now acts as board member and strategic advisor for Peptinov.